Search research articles
Contact Us
Filters
Showing results (21-30 of 150) with videos related to
Page
of 15
Sort By:
Drug Testing and Analysis
|
October 25, 2021
Sports drug testing and the athletes' exposome
Mario Thevis, Tiia Kuuranne, Matthew Fedoruk, et al.
Drug Testing and Analysis
|
January 31, 2012
Annual banned-substance review: analytical approaches in human sports drug testing
Mario Thevis, Tiia Kuuranne, Hans Geyer, et al.
Rapid Communications in Mass Spectrometry : RCM
|
November 13, 2019
Elevated urinary cobalt concentrations identified in routine doping controls can originate from vitamin B<sub>12</sub>
Andre Knoop, Christian Görgens, Hans Geyer, et al.
European Journal of Mass Spectrometry (Chichester, England)
|
October 6, 2005
Identification of fentanyl, alfentanil, sufentanil, remifentanil and their major metabolites in human urine by liquid chromatography/tandem mass spectrometry for doping control purposes
Mario Thevis, Hans Geyer, Daniel Bahr, et al.
Journal of Mass Spectrometry : JMS
|
June 4, 2005
Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry
Mario Thevis, Hans Geyer, Ute Mareck, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
April 5, 2016
Sports drug testing using complementary matrices: Advantages and limitations
Mario Thevis, Hans Geyer, Laura Tretzel, et al.
Analytical Science Advances
|
May 8, 2024
Probing for the presence of semenogelin in human urine by immunological and chromatographic-mass spectrometric methods in the context of sports drug testing
Johanna Breuer, Andreas Thomas, Hans Geyer, et al.
Drug Testing and Analysis
|
January 22, 2011
Annual banned-substance review: analytical approaches in human sports drug testing
Mario Thevis, Tiia Kuuranne, Hans Geyer, et al.
Drug Testing and Analysis
|
February 4, 2021
Do dried blood spots have the potential to support result management processes in routine sports drug testing?-Part 2: Proactive sampling for follow-up investigations concerning atypical or adverse analytical findings
Mario Thevis, Tiia Kuuranne, Andreas Thomas, et al.
Drug Testing and Analysis
|
November 26, 2016
Annual banned-substance review: analytical approaches in human sports drug testing
Mario Thevis, Tiia Kuuranne, Hans Geyer, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 150) with videos related to
Sort By:
Page
of 15
Drug Testing and Analysis
|
October 25, 2021
Sports drug testing and the athletes' exposome
Mario Thevis, Tiia Kuuranne, Matthew Fedoruk, et al.
Drug Testing and Analysis
|
January 31, 2012
Annual banned-substance review: analytical approaches in human sports drug testing
Mario Thevis, Tiia Kuuranne, Hans Geyer, et al.
Rapid Communications in Mass Spectrometry : RCM
|
November 13, 2019
Elevated urinary cobalt concentrations identified in routine doping controls can originate from vitamin B<sub>12</sub>
Andre Knoop, Christian Görgens, Hans Geyer, et al.
European Journal of Mass Spectrometry (Chichester, England)
|
October 6, 2005
Identification of fentanyl, alfentanil, sufentanil, remifentanil and their major metabolites in human urine by liquid chromatography/tandem mass spectrometry for doping control purposes
Mario Thevis, Hans Geyer, Daniel Bahr, et al.
Journal of Mass Spectrometry : JMS
|
June 4, 2005
Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry
Mario Thevis, Hans Geyer, Ute Mareck, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
April 5, 2016
Sports drug testing using complementary matrices: Advantages and limitations
Mario Thevis, Hans Geyer, Laura Tretzel, et al.
Analytical Science Advances
|
May 8, 2024
Probing for the presence of semenogelin in human urine by immunological and chromatographic-mass spectrometric methods in the context of sports drug testing
Johanna Breuer, Andreas Thomas, Hans Geyer, et al.
Drug Testing and Analysis
|
January 22, 2011
Annual banned-substance review: analytical approaches in human sports drug testing
Mario Thevis, Tiia Kuuranne, Hans Geyer, et al.
Drug Testing and Analysis
|
February 4, 2021
Do dried blood spots have the potential to support result management processes in routine sports drug testing?-Part 2: Proactive sampling for follow-up investigations concerning atypical or adverse analytical findings
Mario Thevis, Tiia Kuuranne, Andreas Thomas, et al.
Drug Testing and Analysis
|
November 26, 2016
Annual banned-substance review: analytical approaches in human sports drug testing
Mario Thevis, Tiia Kuuranne, Hans Geyer, et al.
Page
of 15